AwesomeCapital
Search This Blog
Friday, May 31, 2019
Ascendis Pharma target raised by Canaccord
To $144 from $133; maintains Buy.
https://www.benzinga.com/stock/ASND/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.